Bellerophon Therapeutics (BLPH) Tops Q1 EPS by 75c

Bellerophon Therapeutics (NASDAQ: BLPH) reported Q1 EPS of $0.27, $0.75 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $5.64 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Benchmark Starts Boyd Gaming (BYD) at Buy
• Playboy to buy back 16.6M shares from Fortress at $1.05 each